Iceland· IS-EU/1/17/1252/001
Fasenra
A benralizumab product containing benralizumabum inn, registered in Iceland by AstraZeneca AB. The same ATC class is registered in 16 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Benralizumab is registered in 16 of 19 countries.
Countries holding a registration under ATC R03DX10 (benralizumab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Benralizumab · ATC R03DX10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Benralizumabum INN
- Manufacturer
- AstraZeneca AB
- Country
- Iceland (IS)
- ATC code
- R03DX10
- ATC class
- Benralizumab
- Defined daily dose
- 0.54 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean1939751 ml x1 áfsprISK 372920
- ean4496971 ml x1 áfpenISK 372920
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benralizumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayFasenraAstraZeneca AB (2)
- CzechiaFASENRAAstraZeneca AB, Södertälje
- SpainFASENRA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAstrazeneca Ab
- United KingdomFasenra 30mg/1ml solution for injection pre-filled pensAstraZeneca UK Ltd
- SwedenFasenra 30 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- BelgiumFasenra 30 mgAstraZeneca
- SwitzerlandFasenra
- FinlandFasenraOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Fasenra
- Norway · Fasenra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7657adf1-e614-4bb7-a9b9-4bc43c4ad7d2 GET /v1/drugs/7657adf1-e614-4bb7-a9b9-4bc43c4ad7d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "R03DX10",
"marketed": true,
"strength": "30 mg",
"ma_number": "EU/1/17/1252/001",
"substance": "Benralizumabum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í ofnæmis- og lungnasjúkdómum",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "43108"
}See everything about benralizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.